Asper Nephrology

We have launched Asper Nephrology testing portfolio to expand our testing menu and cover more clinical areas. The new portfolio includes tests for common monogenic diseases, as well as complex disorders. To establish the genetic cause of renal diseases we use next-generation sequencing technology to accommodate a broad differential diagnosis. CNV analysis based on sequencing data is also available to enhance precise diagnosis. Visit to see the full list of tests.

CNV analysis

We have integrated copy number variation (CNV) detection tool into our everyday workflow. CNV analysis is now available as a new testing option for all NGS panels and whole exome sequencing. 

View the complete list of all tests

Asper Cardiogenetics updates

We now offer an NGS panel for Hereditary Hemorrhagic Telangiectasia. Additionally, Noonan Syndrome test has been upgraded to Noonan Spectrum Disorders/Rasopathies test including several new disease-causing genes. All NGS panels in Asper Cardiogenetics testing menu are covered by CNV analysis based on sequencing data. Visit to learn more.

Updated Asper Oncogenetics menu

We have updated our Asper Oncogenetics menu. Genetic testing for Prostate Cancer is now available. The testing includes sequencing of the panel of genes and CNV analysis. Other NGS panels in the Asper Oncogenetics menu now also include CNV analysis. View our updated pricelist at Oncogenetics

Asper Dermatology

We are proud to announce a brand new testing menu – Asper Dermatology, which includes gene panels targeting the diagnostics of different skin related inherited disorders. New panels also facilitate differential diagnosis of diseases with overlapping features. Visit to find out more.

Updates in Asper Ophthalmics

Asper Ophthalmics testing menu has been updated with Senior-Loken Syndrome gene panel. We have also added a number of genes to Cone-Rod Dystrophy, Vitelliform Macular Dystrophy, and comprehensive eye diseases panels. Comprehensive eye diseases panel now covers 283 genes associated with different eye disorders. View updated testing options at

Asper Biogene at EAN Congress 2018

We will be attending the 4th Congress of the European Academy of Neurology in Lisbon, 16-19 June. Do not miss the opportunity to get informed about recent developments and news in clinical neurology. Stop by the exhibition hall to learn about Asper Neurogenetics tests and get acquainted with our experts. Looking forward to meeting you at booth #C24!

Del/dup analysis

Del/dup analysis can now be ordered in addition to NGS panels. Read more about upgraded testing options at each portfolio or see the price list Feel free to contact us if there are any additional genes you would need to be included in the analysis.

Congenital Myopathy and Distal Myopathy NGS panel

Congenital Myopathy and Distal Myopathy NGS panel has been added to Asper Neurogenetics portfolio. The new panel includes analysis of 43 genes linked to numerous types of myopathy. Learn more about test

We would be very grateful for any comments on whether this panel can enhance your testing activities or additional genes/conditions should be involved in the panel. Contact us at info[at] and give your feedback.

End-of-Year Price Reduction!

All our catalogue prices will be reduced by 10% for the next two months. Use the great opportunity and make sure  to place your order before January 31, 2018.

Asper Metabolic Disorders

Asper Biogene is pleased to introduce our new testing portfolio of metabolic disorders. Single gene tests as well as multigene panels are included in Asper Metabolic Disorders’ menu. Glycogen and lysosomal storage diseases, fatty acid oxidation disorders, and urea cycle disorders are represented among others.

Full list of tests is available on

New tests in Asper Cardiogenetics

We have expanded our selection of cardiovascular genetic tests to include tests for different types of dyslipidemias, cardiomyopathies, and arrhythmias.  In addition, pulmonary arterial hypertension test has been upgraded with a set of genes to facilitate differential diagnosis. Full list of tests is available:

Skeletal Ciliopathies

Asper Dysmorphology now includes NGS panel for the diagnostics of skeletal ciliopathies. The panel encompasses testing of different forms of short-rib thoracic dysplasia as well as phenotypically overlapping disorders like cranioectodermal dysplasias. For further information visit

Asper Endocrinology now launched

Asper Endocrinology testing portfolio has been launched now. Our latest testing selection is designed for the diagnostics of both monogenic, and complex hereditary endocrine disorders.

Since molecular diagnostics has become the daily practice of endocrinology we are to provide valuable tool for clinicians in order to facilitate diagnosing, optimize treatment, and identify at risk family members.

List of the tests is available on